Close

Acorda Therapeutics (ACOR) Tops Q1 EPS by 18c

May 3, 2012 6:58 AM EDT
Acorda Therapeutics (NASDAQ: ACOR) reported Q1 EPS of $0.36, $0.18 better than the analyst estimate of $0.18. Revenue for the quarter came in at $71.25 million versus the consensus estimate of $70.95 million.

For earnings history and earnings-related data on Acorda Therapeutics (ACOR) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings